Intelligent Regenerative Medicine Process Management Solution

Exhibitor: PURPLE WIN INTERATIONAL LIMITED.

Booth No: M625

Characteristic

Purple Win focuses on the digital management needs of regenerative medicine and cell manufacturing processes by integrating AI-based image analysis with process management tools. This solution supports cell therapy R&D and manufacturing teams in improving quality monitoring, operational efficiency, and data traceability.

Cytometa Intelligent Cell Image Analysis System, developed by Quastella, is designed for regenerative medicine and cell process development. Using deep learning technology, the system identifies subtle morphological changes in cell images and converts them into quantifiable quality indicators. It can support culture condition screening, release criteria assistance, cell bank management, and process stability assessment for clinically relevant cell types such as UC-MSCs, ADSCs, and iPSCs.

Regenerative Medicine Integrated Management System, developed by Shibuya Corporation, integrates environmental management, manufacturing management, and standard operating procedure (SOP) management to support an electronic workflow from order receipt to shipment. The system enables real-time adjustment of cell production schedules and allows operators to perform electronic operations through tablet computers and barcode systems, including SOP form completion, warehouse inbound/outbound management, and recording of personnel, time, location, and operation details.

By combining cell image quality analysis with process operation management, Purple Win helps customers establish a more visualized, traceable, and consistent cell process management environment, supporting regenerative medicine R&D, preclinical process development, and future scale-up manufacturing.